CD19 and neoplasm: To evaluate whether NSAIDs could affect the quality of CD19.CAR-T cells as well, the activation capacity, the cytokine release profile and the proliferation of CD19.CAR-T cells were examined after stimulation by tumor cells in the presence of NSAIDs.